Related references
Note: Only part of the references are listed.Genetic polymorphisms of human hepatic OATPs: functional consequences and effect on drug pharmacokinetics
Yingmin Nie et al.
XENOBIOTICA (2020)
Drug-nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3)
Bianca Vora et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2020)
Advances and Challenges in Rational Drug Design for SLCs
Rachel-Ann A. Garibsingh et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
A Network of SLC and ABC Transporter and DME Genes Involved in Remote Sensing and Signaling in the Gut-Liver-Kidney Axis
Sara Brin Rosenthal et al.
SCIENTIFIC REPORTS (2019)
Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective
Avner Schlessinger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Transporters Involved in Metformin Pharmacokinetics and Treatment Response
Xiaomin Liang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Do Medications Commonly Prescribed to Patients with Peripheral Arterial Disease Have an Effect on Nutritional Status? A Review of the Literature
Renee Fenton et al.
ANNALS OF VASCULAR SURGERY (2016)
A Call for Systematic Research on Solute Carriers
Adrian Cesar-Razquin et al.
CELL (2015)
Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3)
Xiaomin Liang et al.
MOLECULAR PHARMACEUTICS (2015)
SLC transporters as therapeutic targets: emerging opportunities
Lawrence Lin et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Share Paper
